Analysis of deaths in patients awaiting heart transplantation: impact on patient selection criteria. 1996

G A Haywood, and P R Rickenbacher, and P T Trindade, and L Gullestad, and J P Jiang, and J S Schroeder, and R Vagelos, and P Oyer, and M B Fowler
Division of Cardiovascular Medicine and Surgery, Stanford University School of Medicine, California 94305-5246, USA.

OBJECTIVE To analyse the clinical characteristics of patients who died on the Stanford heart transplant waiting list and to develop a method for risk stratifying status 2 patients (outpatients). METHODS Data were reviewed from all patients over 18 years, excluding retransplants, who were accepted for heart transplantation over an eight year period from 1986 to 1994. RESULTS 548 patients were accepted for heart transplantation; 53 died on the waiting list, and 52 survived on the waiting list for over one year. On multivariate analysis only peak oxygen consumption (peak VO2: 11.7 (SD 2.7) v 15.1 (5.2) ml/kg/min, P = 0.02) and cardiac output (3.97 (1.03) v 4.79 (1.06) litres/min, P = 0.04) were found to be independent prognostic risk factors. Peak VO2 and cardiac index (CI) were then analysed in the last 141 consecutive patients accepted for cardiac transplantation. All deaths and 88% of the deteriorations to status 1 on the waiting list occurred in patients with either a CI < 2.0 or a VO2 < 12. In those with a CI < 2.0 and a VO2 < 12, 38% died or deteriorated to status 1 in the first year on the waiting list. Patients with CI > or = 2.0 and a VO2 > or = 12 all survived throughout follow up. Using a Cox's proportional hazards model with CI and peak VO2 as covariates, tables were constructed predicting the chance of surviving for (a) 60 days and (b) 1 year on the waiting list. CONCLUSIONS These data provide a basis for risk stratification of status 2 patients on the heart transplant waiting list.

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010101 Oxygen Consumption The rate at which oxygen is used by a tissue; microliters of oxygen STPD used per milligram of tissue per hour; the rate at which oxygen enters the blood from alveolar gas, equal in the steady state to the consumption of oxygen by tissue metabolism throughout the body. (Stedman, 25th ed, p346) Consumption, Oxygen,Consumptions, Oxygen,Oxygen Consumptions
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D002302 Cardiac Output The volume of BLOOD passing through the HEART per unit of time. It is usually expressed as liters (volume) per minute so as not to be confused with STROKE VOLUME (volume per beat). Cardiac Outputs,Output, Cardiac,Outputs, Cardiac
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006331 Heart Diseases Pathological conditions involving the HEART including its structural and functional abnormalities. Cardiac Disorders,Heart Disorders,Cardiac Diseases,Cardiac Disease,Cardiac Disorder,Heart Disease,Heart Disorder
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012189 Retrospective Studies Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons. Retrospective Study,Studies, Retrospective,Study, Retrospective
D012307 Risk Factors An aspect of personal behavior or lifestyle, environmental exposure, inborn or inherited characteristic, which, based on epidemiological evidence, is known to be associated with a health-related condition considered important to prevent. Health Correlates,Risk Factor Scores,Risk Scores,Social Risk Factors,Population at Risk,Populations at Risk,Correlates, Health,Factor, Risk,Factor, Social Risk,Factors, Social Risk,Risk Factor,Risk Factor Score,Risk Factor, Social,Risk Factors, Social,Risk Score,Score, Risk,Score, Risk Factor,Social Risk Factor
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor

Related Publications

G A Haywood, and P R Rickenbacher, and P T Trindade, and L Gullestad, and J P Jiang, and J S Schroeder, and R Vagelos, and P Oyer, and M B Fowler
October 1992, Transplantation proceedings,
G A Haywood, and P R Rickenbacher, and P T Trindade, and L Gullestad, and J P Jiang, and J S Schroeder, and R Vagelos, and P Oyer, and M B Fowler
June 1990, Wiener medizinische Wochenschrift (1946),
G A Haywood, and P R Rickenbacher, and P T Trindade, and L Gullestad, and J P Jiang, and J S Schroeder, and R Vagelos, and P Oyer, and M B Fowler
April 2010, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation,
G A Haywood, and P R Rickenbacher, and P T Trindade, and L Gullestad, and J P Jiang, and J S Schroeder, and R Vagelos, and P Oyer, and M B Fowler
September 2013, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases,
G A Haywood, and P R Rickenbacher, and P T Trindade, and L Gullestad, and J P Jiang, and J S Schroeder, and R Vagelos, and P Oyer, and M B Fowler
May 1996, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists,
G A Haywood, and P R Rickenbacher, and P T Trindade, and L Gullestad, and J P Jiang, and J S Schroeder, and R Vagelos, and P Oyer, and M B Fowler
January 2017, JACC. Clinical electrophysiology,
G A Haywood, and P R Rickenbacher, and P T Trindade, and L Gullestad, and J P Jiang, and J S Schroeder, and R Vagelos, and P Oyer, and M B Fowler
May 2017, Current opinion in cardiology,
G A Haywood, and P R Rickenbacher, and P T Trindade, and L Gullestad, and J P Jiang, and J S Schroeder, and R Vagelos, and P Oyer, and M B Fowler
January 1993, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation,
G A Haywood, and P R Rickenbacher, and P T Trindade, and L Gullestad, and J P Jiang, and J S Schroeder, and R Vagelos, and P Oyer, and M B Fowler
February 2010, The Thoracic and cardiovascular surgeon,
G A Haywood, and P R Rickenbacher, and P T Trindade, and L Gullestad, and J P Jiang, and J S Schroeder, and R Vagelos, and P Oyer, and M B Fowler
November 1998, Journal of psychosomatic research,
Copied contents to your clipboard!